Home
>
National Drug Code (NDC)
>
INNOPRAN
INNOPRAN - 0173-0791-01 - (propranolol hydrochloride)
Drug Information of INNOPRAN
| Product NDC: | 0173-0791 |
| Proprietary Name: | INNOPRAN |
| Non Proprietary Name: | propranolol hydrochloride |
| Active Ingredient(s): | 120 mg/1 & nbsp; propranolol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of INNOPRAN
| Product NDC: | 0173-0791 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021438 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080328 |
Package Information of INNOPRAN
| Package NDC: | 0173-0791-01 |
| Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0173-0791-01) |
NDC Information of INNOPRAN
| NDC Code | 0173-0791-01 |
| Proprietary Name | INNOPRAN |
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0173-0791-01) |
| Product NDC | 0173-0791 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | propranolol hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080328 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | PROPRANOLOL HYDROCHLORIDE |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
